CLS Holdings USA, Inc. (CLSH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CLS Holdings USA, Inc. (CLSH) trades at $0.04 with AI Score 43/100 (Grade C). CLS Holdings USA, Inc. is a diversified cannabis enterprise focused on extracting and transforming cannabinoids into various concentrates like oils, waxes, and edibles. Market cap: $5.94M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CLSH: CLSH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CLSH against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CLSH: the 1 perspectives are evenly split.
How is this calculated? →CLS Holdings USA, Inc. (CLSH) Healthcare & Pipeline Overview
CLS Holdings USA, Inc. is a U.S.-based diversified cannabis enterprise specializing in cannabinoid extraction and conversion into concentrates, including oils, waxes, and edibles. Operating under Oasis Cannabis and City Trees brands, it serves medical and recreational markets, provides processing services, and distributes cannabis strains.
What Is the Investment Thesis for CLSH?
CLS Holdings USA, Inc. operates as a diversified cannabis enterprise with a strategic focus on cannabinoid extraction and conversion, positioning itself within a growing segment of the U.S. cannabis market. The company's business model is underpinned by its ability to produce a variety of concentrates, including oils, waxes, and edibles, marketed under established brands like Oasis Cannabis and City Trees. Key value drivers include its specialized extraction capabilities, which contribute to a gross margin of 42.7%, indicating efficiency in its core production processes. Growth catalysts for CLS Holdings include the ongoing expansion of legal cannabis markets across U.S. states and the increasing consumer demand for cannabis extracts, which are central to the company's product offerings. Potential federal regulatory reforms could further enhance market access and operational efficiencies. However, the company faces significant challenges, notably a profit margin of -22.5%, reflecting current unprofitability. Its market capitalization of $5.94M and OTC Other listing status introduce risks associated with lower liquidity, less stringent disclosure requirements, and potential difficulties in accessing traditional capital markets. The company's Beta of 1.18 suggests higher price volatility compared to the broader market, which investors may want to evaluate.
Based on FMP financials and quantitative analysis
CLSH Key Highlights
- Market Capitalization: $0.01 billion, indicating a micro-cap company within the cannabis sector.
- Gross Margin: 42.7%, suggesting efficiency in production relative to the cost of goods sold for its cannabis products and services.
- Profit Margin: -22.5%, reflecting current unprofitability and operational challenges.
- Employee Base: 80 employees, indicating a relatively lean operation for its diversified cannabis activities.
- Beta: 1.18, suggesting higher volatility compared to the broader market, which is common for companies in emerging industries like cannabis.
Who Are CLSH's Competitors?
CLSH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CLSH's Key Strengths?
- Diversified cannabis operations spanning extraction, product manufacturing, distribution, and consulting.
- Specialized expertise in cannabinoid extraction and conversion into various concentrates.
- Established brand recognition with Oasis Cannabis and City Trees in the market.
- Gross margin of 42.7%, indicating efficiency in its core production processes.
What Are CLSH's Weaknesses?
- Negative profit margin of -22.5%, reflecting current unprofitability.
- Small market capitalization of $5.94M, suggesting limited financial scale.
- OTC Other listing, which implies lower liquidity and less stringent disclosure requirements.
- Dependence on evolving and fragmented state-level cannabis regulations.
What Could Drive CLSH Stock Higher?
- Potential federal cannabis regulatory reform in the U.S., such as descheduling or the passage of the SAFE Banking Act, which could significantly improve market access and financial operations.
- Expansion of legal cannabis markets in new U.S. states, creating opportunities for CLS Holdings to broaden its geographic reach and distribution networks.
- Continued growth in consumer demand for cannabis concentrates and edibles, aligning with the company's core business of cannabinoid extraction and product manufacturing.
- Successful execution of product innovation and market penetration strategies for its Oasis Cannabis and City Trees brands, enhancing market share and brand loyalty.
What Are the Key Risks for CLSH?
- Financial-distress signal — its Altman Z-Score of -20.93 sits in the distress zone (elevated bankruptcy risk).
- Regulatory uncertainty and fragmentation across U.S. states, which complicates interstate commerce and consistent operational frameworks.
- Intense competition within the cannabis industry, particularly in the extraction and branded product segments, potentially impacting pricing and market share.
- Challenges in achieving sustained profitability, as indicated by the -22.5% profit margin, requiring careful management of costs and revenue growth.
- Limited access to traditional capital markets due to federal illegality of cannabis and the company's OTC listing status, hindering funding for growth.
- Risks associated with OTC Other listing, including lower liquidity, less stringent disclosure requirements, and increased price volatility.
What Are the Growth Opportunities for CLSH?
- The ongoing trend of state-level cannabis legalization across the United States presents a significant growth avenue for CLS Holdings USA, Inc. As more states approve medical or recreational cannabis use, new markets open up, allowing the company to expand its distribution networks and product offerings. This expansion could involve entering new jurisdictions directly or through strategic partnerships, tapping into a growing consumer base. The total U.S. legal cannabis market is projected to continue its robust growth, offering substantial opportunities for companies with established extraction capabilities like CLS Holdings, particularly over the next five to ten years as regulatory frameworks mature.
- Consumer preferences are increasingly shifting towards cannabis concentrates, including oils, waxes, edibles, and shatters, due to their potency, discretion, and diverse consumption methods. This trend directly aligns with CLS Holdings USA, Inc.'s core business of cannabinoid extraction and conversion. The market for cannabis extracts is experiencing rapid growth, driven by product innovation and evolving consumer tastes. By focusing on high-quality and diverse extract products under its Oasis Cannabis and City Trees brands, CLS Holdings is well-positioned to capitalize on this expanding demand over the next several years, reinforcing its market share in this high-growth segment.
- In a fragmented and rapidly evolving industry, strategic partnerships and targeted acquisitions represent a compelling growth opportunity. CLS Holdings USA, Inc. could leverage its specialized extraction expertise and established brands to form alliances with cultivators, dispensaries, or technology providers to enhance its market reach, operational efficiency, or product innovation. Acquiring smaller, complementary businesses could also enable the company to consolidate market share, gain access to new licenses, or expand its geographic footprint more rapidly, potentially leading to economies of scale and increased profitability over the medium term, typically within a 3-5 year horizon.
- Developing and introducing new, innovative cannabis products can capture emerging consumer segments and differentiate CLS Holdings USA, Inc. from competitors. This could involve creating novel cannabinoid formulations, developing advanced delivery methods for edibles or topicals, or exploring products with specific therapeutic profiles. By continuously investing in research and development, the company can stay ahead of market trends and cater to evolving consumer demands for specialized cannabis products. Such diversification could enhance brand loyalty and open new revenue streams, contributing to long-term growth and market relevance over a 2-7 year timeline.
- The potential for federal cannabis regulatory reform in the United States, such as descheduling cannabis or passing legislation like the SAFE Banking Act, represents a transformative growth opportunity. Federal reform could alleviate significant operational and financial constraints currently faced by cannabis companies, including limited access to traditional banking services and interstate commerce. This would potentially lower operating costs, facilitate easier capital access, and allow for broader market expansion, significantly impacting CLS Holdings USA, Inc.'s growth trajectory and profitability over the long term, assuming legislative progress occurs within the next 1-5 years.
What Opportunities Does CLSH Have?
- Growing demand for cannabis extracts and concentrates across U.S. markets.
- Potential for federal cannabis regulatory reform, such as descheduling or banking reform.
- Expansion into new U.S. states as more jurisdictions legalize cannabis.
- Strategic partnerships or acquisitions to consolidate market share and expand reach.
What Threats Does CLSH Face?
- Intense competition from numerous established and emerging players in the cannabis industry.
- Ongoing regulatory uncertainty and the risk of adverse policy changes at state or federal levels.
- Challenges in accessing traditional capital markets due to federal illegality and OTC listing status.
- Competition from the illicit cannabis market, which can undercut legal prices.
What Are CLSH's Competitive Advantages?
- Specialized expertise in cannabinoid extraction and conversion processes, enabling production of diverse concentrates.
- Established brand recognition with Oasis Cannabis and City Trees, fostering consumer loyalty in key markets.
- Diversified service portfolio, including processing, consulting, and distribution, creating multiple revenue streams.
- Operational presence within regulated U.S. cannabis markets, navigating complex state-level compliance requirements.
What Does CLSH Do?
CLS Holdings USA, Inc., a diversified cannabis enterprise, was established in 2014 and maintains its headquarters in Miami, Florida. The company's core operational focus within the United States revolves around the intricate process of extracting and transforming cannabinoids from cannabis plants. This specialization enables CLS Holdings to convert raw cannabinoids into a diverse array of concentrates, which include popular forms such as oils, waxes, edibles, and shatters. The company's comprehensive service and product portfolio extends across several key areas of the cannabis value chain. It actively supplies organic medical cannabis to licensed retailers, ensuring access to quality products for therapeutic use. Furthermore, CLS Holdings provides recreational marijuana products to authorized distributors and retailers, catering to the expanding adult-use market. A significant aspect of its business model involves offering its own in-house derived extraction products, such as various oils and waxes, which are critical components for both consumer and pharmaceutical applications. Beyond product manufacturing, CLS Holdings delivers specialized processing and extraction services to licensed medical cannabis cultivators, leveraging its expertise to support other industry players. The company also plays a role in the cultivation supply chain by distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Complementing these offerings, CLS Holdings provides consulting expertise to a wide range of cannabis-related businesses, including cultivators, dispensaries, and laboratories, helping them navigate the complexities of the industry. Additionally, it performs toll processing services, further diversifying its revenue streams. CLS Holdings USA, Inc. strategically markets its products under two well-known brand names: Oasis Cannabis and City Trees, with its concentrates serving both recreational and pharmaceutical purposes, underscoring its broad market reach and product versatility.
What Products and Services Does CLSH Offer?
- Extract cannabinoids from cannabis plants, specializing in isolation and conversion.
- Convert cannabinoids into various concentrates, including oils, waxes, edibles, and shatters.
- Supply organic medical cannabis products to licensed retailers.
- Provide recreational marijuana products to authorized distributors and retailers.
- Offer its own in-house derived extraction products, such as oils and waxes, under proprietary brands.
- Deliver specialized processing and extraction services for licensed medical cannabis cultivators.
- Distribute cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers.
- Provide consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories.
- Perform toll processing services for other cannabis entities.
How Does CLSH Make Money?
- Generates revenue from the direct sale of its proprietary cannabis concentrates (oils, waxes, edibles) under the Oasis Cannabis and City Trees brand names.
- Earns income by supplying organic medical cannabis and recreational marijuana products to licensed retailers and distributors.
- Receives fees for providing specialized processing, extraction, and toll processing services to licensed medical cannabis cultivators.
- Derives revenue from the distribution of cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers.
- Collects consulting fees for offering expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories.
What Industry Does CLSH Operate In?
CLS Holdings USA, Inc. operates within the dynamic and rapidly evolving U.S. cannabis industry, specifically focusing on the extraction, processing, and distribution of cannabinoid-derived products. The broader market is characterized by increasing state-level legalization, which fuels demand for both medical and recreational cannabis. A significant market trend is the growing consumer preference for cannabis extracts and concentrates, such as oils, waxes, and edibles, which offer potency and diverse consumption methods. The competitive landscape is fragmented, comprising numerous cultivators, processors, and retailers, often operating regionally due to federal restrictions. CLS Holdings positions itself as a specialized player in the extraction segment, leveraging its in-house capabilities and established brands like Oasis Cannabis and City Trees to differentiate itself in a competitive environment where product quality and brand recognition are increasingly important.
Who Are CLSH's Key Customers?
- Licensed medical cannabis retailers seeking organic medical cannabis products.
- Authorized recreational marijuana distributors and retailers purchasing recreational products.
- Licensed medical cannabis cultivators requiring specialized processing and extraction services.
- Licensed medical cannabis growers acquiring vegetative cannabis cuttings for cultivation.
- Various cannabis-related businesses (cultivators, dispensaries, laboratories) utilizing consulting expertise.
Net buyingInsider Activity
The most recent 12 insider filings for CLS Holdings USA, Inc. break down as 8 sales and 4 purchases. On net that is roughly 36.8M shares acquired (about $692K) — insiders putting money in tends to read as conviction.
FY2027 estForward Outlook
Wall Street analysts project CLS Holdings USA, Inc. revenue of about $17.3M for fiscal 2027, with EPS near $0.00.
F-Score 6/9Financial Health
CLS Holdings USA, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -20.93 places it in the distress zone, a signal of elevated financial risk.
ROE 37%Key Financial Metrics
Return on equity for CLS Holdings USA, Inc. stands at 36.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -56.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 11.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.23 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -125.9%, the inverse of the P/E and a quick read on earnings relative to price.
CLS Holdings USA, Inc. (CLSH) Valuation Context
Valued at $5.94M, CLSH is classified as a micro-cap stock. Relative to its peer group, CLSH's quantitative score of 43/100 is below the peer average of 66/100.
Company Profile
CLS Holdings USA, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Andrew J. Glashow. CLSH has traded publicly since 2015.
CLSH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified cannabis operations spanning extraction, product manufacturing, distribution, and consulting.
- Specialized expertise in cannabinoid extraction and conversion into various concentrates.
- Established brand recognition with Oasis Cannabis and City Trees in the market.
- Gross margin of 42.7%, indicating efficiency in its core production processes.
Bear Case
- Negative profit margin of -22.5%, reflecting current unprofitability.
- Small market capitalization of $5.94M, suggesting limited financial scale.
- OTC Other listing, which implies lower liquidity and less stringent disclosure requirements.
- Dependence on evolving and fragmented state-level cannabis regulations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CLSH Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
CLSH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLSH.
Price Targets
Wall Street price target analysis for CLSH.
CLSH MoonshotScore
What does this score mean?
The MoonshotScore rates CLSH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andrew J. Glashow
Chief Executive Officer
Andrew J. Glashow serves as the Chief Executive Officer of CLS Holdings USA, Inc., overseeing the company's operations and managing its 80 employees. While specific details regarding Mr. Glashow's comprehensive career history, educational background, and previous executive roles prior to joining CLS Holdings USA, Inc. are not provided in the available data, his leadership is central to the company's strategic direction within the dynamic cannabis industry.
Track Record: Under Andrew J. Glashow's leadership, CLS Holdings USA, Inc. has continued to focus on its core business of cannabinoid extraction and conversion, expanding its product lines under the Oasis Cannabis and City Trees brands. Specific achievements, strategic decisions, or company milestones directly attributable to his tenure are not detailed in the provided information.
CLSH OTC Market Information
CLS Holdings USA, Inc. trades on the OTC Other tier of the over-the-counter market. This tier is distinct from major exchanges like the NYSE or NASDAQ, which have stringent listing requirements regarding financial health, public float, and corporate governance. Companies on the OTC Other tier typically have less comprehensive public disclosure obligations, often providing limited or no financial reporting to a centralized authority. This environment is generally associated with smaller, less established companies or those that do not meet the criteria for higher OTC tiers or major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Less stringent reporting requirements compared to major exchanges, leading to reduced transparency for investors.
- Lower trading volumes and wider bid-ask spreads, resulting in limited liquidity and potential difficulty in exiting positions.
- Increased price volatility due to fewer market participants and less regulatory oversight.
- Limited analyst coverage and institutional interest, which can hinder accurate valuation and market efficiency.
- Higher potential for market manipulation due to the less regulated trading environment.
- Verify any available financial statements and audit reports directly from the company or third-party sources.
- Research the background and track record of management and board members.
- Assess the company's business model, competitive landscape, and operational viability.
- Understand the specific regulatory environment and compliance status within the cannabis industry.
- Examine any press releases, corporate websites, or investor relations materials for recent updates.
- Evaluate the company's capital structure and potential for dilution.
- Consider the overall market risks associated with the cannabis sector and micro-cap stocks.
- Established brand names: Oasis Cannabis and City Trees, indicating market presence and product recognition.
- Diversified operations: Involvement in extraction, product manufacturing, distribution, and consulting services.
- Physical headquarters: Located in Miami, Florida, suggesting a tangible operational base.
- Employee count: 80 employees, indicating a functioning organizational structure and active operations.
CLSH Healthcare Stock FAQ
What is CLS Holdings USA, Inc.'s primary business focus within the cannabis industry?
CLS Holdings USA, Inc. primarily operates as a diversified cannabis enterprise specializing in the extraction and transformation of cannabinoids within the United States. The company's core activities involve isolating cannabinoids from cannabis plants and converting them into various concentrates, such as oils, waxes, edibles, and shatters. Beyond manufacturing its own branded products like Oasis Cannabis and City Trees concentrates, CLS Holdings also supplies organic medical cannabis and recreational marijuana products to licensed entities, provides specialized processing and extraction services to cultivators, distributes cannabis strains, and offers consulting expertise to a range of cannabis-related businesses. This integrated approach positions it across multiple segments of the cannabis value chain.
How does CLS Holdings USA, Inc. navigate the complex regulatory environment of the cannabis sector?
CLS Holdings USA, Inc. operates within a highly complex and evolving regulatory landscape characterized by varying state-level cannabis laws and ongoing federal prohibition. The company manages this by focusing its operations exclusively within U.S. states where cannabis is legal for medical or recreational use, ensuring strict adherence to state-specific licensing, cultivation, processing, and distribution regulations. Its business model is built around supplying products and services only to licensed retailers, distributors, and cultivators. While federal illegality presents challenges, such as limited access to traditional banking and capital markets, CLS Holdings maintains compliance with existing state frameworks, positioning itself to adapt to potential future federal reforms.
What are the implications of CLS Holdings USA, Inc. trading on the OTC market?
Trading on the OTC Other tier of the over-the-counter market carries several implications for CLS Holdings USA, Inc. and its investors. This tier typically has less stringent listing and disclosure requirements compared to major exchanges like the NYSE or NASDAQ, and the company's disclosure status is currently "Unknown." This can result in reduced transparency regarding financial performance and operational updates. Furthermore, OTC stocks often experience lower trading volumes and wider bid-ask spreads, leading to limited liquidity. Investors may find it more challenging to buy or sell shares quickly without impacting the price. These factors contribute to increased price volatility and potentially higher investment risk compared to exchange-listed securities.
What are the key factors to evaluate for CLSH?
CLS Holdings USA, Inc. (CLSH) holds an AI score of 43/100 (low). Not financial advice.
How frequently does CLSH data refresh on this page?
CLSH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CLSH's recent stock price performance?
CLS Holdings USA, Inc. (CLSH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified cannabis operations spanning extraction, product manufacturing, distribution, and consulting. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CLSH overvalued or undervalued right now?
Valuing CLS Holdings USA, Inc. (CLSH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CLSH?
Before investing in CLS Holdings USA, Inc. (CLSH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information on CEO's specific background and track record is limited to what was provided in the source data.
- Competitor data (FMP PEER TICKERS) was not provided in the source material.
- Specific details on OTC disclosure status beyond 'Unknown' were not provided in the source material.